2015-2027 Global Inactivated Vaccines Industry Market Research Report, Segment by Player, Type, Application, Marketing Channel, and Region

April 2020 | 136 pages | ID: 2DFB9F55A062EN
Maia Research

Abstracts

The worldwide market for Inactivated Vaccines is estimated to grow at a CAGR of roughly X.X% in the next 8 years, and will reach X.X million US$ in 2027, from X.X million US$ in 2020.

The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in Major Regions, such as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, by type, application and marketing channel. In addition, the report focuses on the driving factors, restraints, opportunities and PEST analysis of major regions.

Major Companies Covered
India Pvt. Ltd. (India)
Johnson & Johnson
GlaxoSmithKline
Emergent BioSolutions, Inc
Pfizer
Astellas Pharma Inc
Sanofi Pasteur
Serum Institute
CSL Limited
MedImmune, LLC
Merck & Co

Major Types Covered
Pneumococcal
Influenza
HPV
Hepatitis
Rotavirus
DTP
Polio
MMR

Major Applications Covered
Pediatric
Adult

Top Countries Data Covered in This Report
United States
Canada
Germany
UK
France
Italy
Spain
Russia
Netherlands
Turkey
Switzerland
Sweden
Poland
Belgium
China
Japan
South Korea
Australia
India
Taiwan
Indonesia
Thailand
Philippines
Malaysia
Brazil
Mexico
Argentina
Columbia
Chile
Saudi Arabia
UAE
Egypt
Nigeria
South Africa

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2027

Contents

1 INTRODUCTION

1.1 Objective of the Study
1.2 Definition of the Market
1.3 Market Scope
  1.3.1 Market Segment by Type, Application and Marketing Channel
  1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa)
1.4 Years Considered for the Study (2015-2027)
1.5 Currency Considered (U.S. Dollar)
1.6 Stakeholders

2 KEY FINDINGS OF THE STUDY

3 MARKET DYNAMICS

3.1 Driving Factors for this Market
3.2 Factors Challenging the Market
3.3 Opportunities of the Global Inactivated Vaccines Market (Regions, Growing/Emerging Downstream Market Analysis)
3.4 Technological and Market Developments in the Inactivated Vaccines Market
3.5 Industry News by Region
3.6 Regulatory Scenario by Region/Country
3.7 Market Investment Scenario Strategic Recommendations Analysis

4 VALUE CHAIN OF THE INACTIVATED VACCINES MARKET

4.1 Value Chain Status
4.2 Upstream Raw Material Analysis
4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
4.4 Distributors/Traders
4.5 Downstream Major Customer Analysis (by Region)

5 GLOBAL INACTIVATED VACCINES MARKET-SEGMENTATION BY TYPE

5.1 Pneumococcal
5.2 Influenza
5.3 HPV
5.4 Hepatitis
5.5 Rotavirus
5.6 DTP
5.7 Polio
5.8 MMR

6 GLOBAL INACTIVATED VACCINES MARKET-SEGMENTATION BY APPLICATION

6.1 Pediatric
6.2 Adult

7 GLOBAL INACTIVATED VACCINES MARKET-SEGMENTATION BY MARKETING CHANNEL

7.1 Traditional Marketing Channel (Offline)
7.2 Online Channel

8 COMPETITIVE INTELLIGENCE – COMPANY PROFILES

8.1 India Pvt. Ltd. (India)
  8.1.1 India Pvt. Ltd. (India) Profile
  8.1.2 India Pvt. Ltd. (India) Sales, Growth Rate and Global Market Share from 2015-2020
  8.1.3 India Pvt. Ltd. (India) Product/Solution Launches and Enhancements Analysis
  8.1.4 India Pvt. Ltd. (India) Business Overview/Recent Development/Acquisitions
8.2 Johnson & Johnson
  8.2.1 Johnson & Johnson Profile
  8.2.2 Johnson & Johnson Sales, Growth Rate and Global Market Share from 2015-2020
  8.2.3 Johnson & Johnson Product/Solution Launches and Enhancements Analysis
  8.2.4 Johnson & Johnson Business Overview/Recent Development/Acquisitions
8.3 GlaxoSmithKline
  8.3.1 GlaxoSmithKline Profile
  8.3.2 GlaxoSmithKline Sales, Growth Rate and Global Market Share from 2015-2020
  8.3.3 GlaxoSmithKline Product/Solution Launches and Enhancements Analysis
  8.3.4 GlaxoSmithKline Business Overview/Recent Development/Acquisitions
8.4 Emergent BioSolutions, Inc
  8.4.1 Emergent BioSolutions, Inc Profile
  8.4.2 Emergent BioSolutions, Inc Sales, Growth Rate and Global Market Share from 2015-2020
  8.4.3 Emergent BioSolutions, Inc Product/Solution Launches and Enhancements Analysis
  8.4.4 Emergent BioSolutions, Inc Business Overview/Recent Development/Acquisitions
8.5 Pfizer
  8.5.1 Pfizer Profile
  8.5.2 Pfizer Sales, Growth Rate and Global Market Share from 2015-2020
  8.5.3 Pfizer Product/Solution Launches and Enhancements Analysis
  8.5.4 Pfizer Business Overview/Recent Development/Acquisitions
8.6 Astellas Pharma Inc
  8.6.1 Astellas Pharma Inc Profile
  8.6.2 Astellas Pharma Inc Sales, Growth Rate and Global Market Share from 2015-2020
  8.6.3 Astellas Pharma Inc Product/Solution Launches and Enhancements Analysis
  8.6.4 Astellas Pharma Inc Business Overview/Recent Development/Acquisitions
8.7 Sanofi Pasteur
  8.7.1 Sanofi Pasteur Profile
  8.7.2 Sanofi Pasteur Sales, Growth Rate and Global Market Share from 2015-2020
  8.7.3 Sanofi Pasteur Product/Solution Launches and Enhancements Analysis
  8.7.4 Sanofi Pasteur Business Overview/Recent Development/Acquisitions
8.8 Serum Institute
  8.8.1 Serum Institute Profile
  8.8.2 Serum Institute Sales, Growth Rate and Global Market Share from 2015-2020
  8.8.3 Serum Institute Product/Solution Launches and Enhancements Analysis
  8.8.4 Serum Institute Business Overview/Recent Development/Acquisitions
8.9 CSL Limited
  8.9.1 CSL Limited Profile
  8.9.2 CSL Limited Sales, Growth Rate and Global Market Share from 2015-2020
  8.9.3 CSL Limited Product/Solution Launches and Enhancements Analysis
  8.9.4 CSL Limited Business Overview/Recent Development/Acquisitions
8.10 MedImmune, LLC
  8.10.1 MedImmune, LLC Profile
  8.10.2 MedImmune, LLC Sales, Growth Rate and Global Market Share from 2015-2020
  8.10.3 MedImmune, LLC Product/Solution Launches and Enhancements Analysis
  8.10.4 MedImmune, LLC Business Overview/Recent Development/Acquisitions
8.11 Merck & Co
  8.11.1 Merck & Co Profile
  8.11.2 Merck & Co Sales, Growth Rate and Global Market Share from 2015-2020
  8.11.3 Merck & Co Product/Solution Launches and Enhancements Analysis
  8.11.4 Merck & Co Business Overview/Recent Development/Acquisitions

9 GLOBAL INACTIVATED VACCINES MARKET-SEGMENTATION BY GEOGRAPHY

10 NORTH AMERICA

10.1 North America Inactivated Vaccines Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
10.2 North America Inactivated Vaccines Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
10.3 North America Inactivated Vaccines Production Analysis from 2015-2020
10.4 North America Inactivated Vaccines Consumption Analysis from 2015-2020
10.5 North America Inactivated Vaccines Import and Export from 2015-2020
10.6 North America Inactivated Vaccines Value, Production and Market Share by Type (2015-2020)
10.7 North America Inactivated Vaccines Consumption, Value and Market Share by Application (2015-2020)
10.8 North America Inactivated Vaccines by Country (United States, Canada)
  10.8.1 North America Inactivated Vaccines Sales by Country (2015-2020)
  10.8.2 North America Inactivated Vaccines Consumption Value by Country (2015-2020)
10.9 North America Inactivated Vaccines Market PEST Analysis

11 EUROPE

11.1 Europe Inactivated Vaccines Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
11.2 Europe Inactivated Vaccines Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
11.3 Europe Inactivated Vaccines Production Analysis from 2015-2020
11.4 Europe Inactivated Vaccines Consumption Analysis from 2015-2020
11.5 Europe Inactivated Vaccines Import and Export from 2015-2020
11.6 Europe Inactivated Vaccines Value, Production and Market Share by Type (2015-2020)
11.7 Europe Inactivated Vaccines Consumption, Value and Market Share by Application (2015-2020)
11.8 Europe Inactivated Vaccines by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium)
  11.8.1 Europe Inactivated Vaccines Sales by Country (2015-2020)
  11.8.2 Europe Inactivated Vaccines Consumption Value by Country (2015-2020)
11.9 Europe Inactivated Vaccines Market PEST Analysis

12 ASIA-PACIFIC

12.1 Asia-Pacific Inactivated Vaccines Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
12.2 Asia-Pacific Inactivated Vaccines Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
12.3 Asia-Pacific Inactivated Vaccines Production Analysis from 2015-2020
12.4 Asia-Pacific Inactivated Vaccines Consumption Analysis from 2015-2020
12.5 Asia-Pacific Inactivated Vaccines Import and Export from 2015-2020
12.6 Asia-Pacific Inactivated Vaccines Value, Production and Market Share by Type (2015-2020)
12.7 Asia-Pacific Inactivated Vaccines Consumption, Value and Market Share by Application (2015-2020)
12.8 Asia-Pacific Inactivated Vaccines by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia)
  12.8.1 Asia-Pacific Inactivated Vaccines Sales by Country (2015-2020)
  12.8.2 Asia-Pacific Inactivated Vaccines Consumption Value by Country (2015-2020)
12.9 Asia-Pacific Inactivated Vaccines Market PEST Analysis

13 LATIN AMERICA

13.1 Latin America Inactivated Vaccines Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
13.2 Latin America Inactivated Vaccines Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
13.3 Latin America Inactivated Vaccines Production Analysis from 2015-2020
13.4 Latin America Inactivated Vaccines Consumption Analysis from 2015-2020
13.5 Latin America Inactivated Vaccines Import and Export from 2015-2020
13.6 Latin America Inactivated Vaccines Value, Production and Market Share by Type (2015-2020)
13.7 Latin America Inactivated Vaccines Consumption, Value and Market Share by Application (2015-2020)
13.8 Latin America Inactivated Vaccines by Country (Brazil, Mexico, Argentina, Columbia, Chile)
  13.8.1 Latin America Inactivated Vaccines Sales by Country (2015-2020)
  13.8.2 Latin America Inactivated Vaccines Consumption Value by Country (2015-2020)
13.9 Latin America Inactivated Vaccines Market PEST Analysis

14 MIDDLE EAST & AFRICA

14.1 Middle East & Africa Inactivated Vaccines Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
14.2 Middle East & Africa Inactivated Vaccines Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
14.3 Middle East & Africa Inactivated Vaccines Production Analysis from 2015-2020
14.4 Middle East & Africa Inactivated Vaccines Consumption Analysis from 2015-2020
14.5 Middle East & Africa Inactivated Vaccines Import and Export from 2015-2020
14.6 Middle East & Africa Inactivated Vaccines Value, Production and Market Share by Type (2015-2020)
14.7 Middle East & Africa Inactivated Vaccines Consumption, Value and Market Share by Application (2015-2020)
14.8 Middle East & Africa Inactivated Vaccines by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)
  14.8.1 Middle East & Africa Inactivated Vaccines Sales by Country (2015-2020)
  14.8.2 Middle East & Africa Inactivated Vaccines Consumption Value by Country (2015-2020)
14.9 Middle East & Africa Inactivated Vaccines Market PEST Analysis

15 FUTURE FORECAST OF THE GLOBAL INACTIVATED VACCINES MARKET FROM 2020-2027

15.1 Future Forecast of the Global Inactivated Vaccines Market from 2020-2027 Segment by Region
15.2 Global Inactivated Vaccines Production and Growth Rate Forecast by Type (2020-2027)
15.3 Global Inactivated Vaccines Consumption and Growth Rate Forecast by Application (2020-2027)

16 APPENDIX

16.1 Methodology
16.2 Research Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Global Inactivated Vaccines Market Value ($) and Growth Rate of Inactivated Vaccines from 2015-2027
Global Inactivated Vaccines Production and Growth Rate Segment by Product Type from 2015-2027
Global Inactivated Vaccines Consumption and Growth Rate Segment by Application from 2015-2027
Figure Inactivated Vaccines Picture
Table Product Specifications of Inactivated Vaccines
Table Driving Factors for this Market
Table Industry News of Inactivated Vaccines Market
Figure Value Chain Status of Inactivated Vaccines
Table Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
Table Distributors/Traders
Table Downstream Major Customer Analysis (by Region, by Preference)
Table Global Inactivated Vaccines Production and Growth Rate Segment by Product Type from 2015-2020
Table Global Inactivated Vaccines Value ($) and Growth Rate Segment by Product Type from 2015-2020
Figure Pneumococcal of Inactivated Vaccines
Figure Influenza of Inactivated Vaccines
Figure HPV of Inactivated Vaccines
Figure Hepatitis of Inactivated Vaccines
Figure Rotavirus of Inactivated Vaccines
Figure DTP of Inactivated Vaccines
Figure Polio of Inactivated Vaccines
Figure MMR of Inactivated Vaccines
Table Global Inactivated Vaccines Consumption and Growth Rate Segment by Application from 2015-2020
Table Global Inactivated Vaccines Value ($) and Growth Rate Segment by Application from 2015-2020
Figure Pediatric of Inactivated Vaccines
Figure Adult of Inactivated Vaccines
Table Global Inactivated Vaccines Consumption and Growth Rate Segment by Marketing Channel from 2015-2020
Table Global Inactivated Vaccines Value ($) and Growth Rate Segment by Marketing Channel from 2015-2020
Figure Traditional Marketing Channel (Offline) of Inactivated Vaccines
Figure Online Channel of Inactivated Vaccines
Table India Pvt. Ltd. (India) Profile (Company Name, Plants Distribution, Sales Region)
Figure India Pvt. Ltd. (India) Sales and Growth Rate from 2015-2020
Figure India Pvt. Ltd. (India) Revenue ($) and Global Market Share from 2015-2020
Table India Pvt. Ltd. (India) Inactivated Vaccines Sales, Price, Revenue, Gross Margin (2015-2020)
Table Johnson & Johnson Profile (Company Name, Plants Distribution, Sales Region)
Figure Johnson & Johnson Sales and Growth Rate from 2015-2020
Figure Johnson & Johnson Revenue ($) and Global Market Share from 2015-2020
Table Johnson & Johnson Inactivated Vaccines Sales, Price, Revenue, Gross Margin (2015-2020)
Table GlaxoSmithKline Profile (Company Name, Plants Distribution, Sales Region)
Figure GlaxoSmithKline Sales and Growth Rate from 2015-2020
Figure GlaxoSmithKline Revenue ($) and Global Market Share from 2015-2020
Table GlaxoSmithKline Inactivated Vaccines Sales, Price, Revenue, Gross Margin (2015-2020)
Table Emergent BioSolutions, Inc Profile (Company Name, Plants Distribution, Sales Region)
Figure Emergent BioSolutions, Inc Sales and Growth Rate from 2015-2020
Figure Emergent BioSolutions, Inc Revenue ($) and Global Market Share from 2015-2020
Table Emergent BioSolutions, Inc Inactivated Vaccines Sales, Price, Revenue, Gross Margin (2015-2020)
Table Pfizer Profile (Company Name, Plants Distribution, Sales Region)
Figure Pfizer Sales and Growth Rate from 2015-2020
Figure Pfizer Revenue ($) and Global Market Share from 2015-2020
Table Pfizer Inactivated Vaccines Sales, Price, Revenue, Gross Margin (2015-2020)
Table Astellas Pharma Inc Profile (Company Name, Plants Distribution, Sales Region)
Figure Astellas Pharma Inc Sales and Growth Rate from 2015-2020
Figure Astellas Pharma Inc Revenue ($) and Global Market Share from 2015-2020
Table Astellas Pharma Inc Inactivated Vaccines Sales, Price, Revenue, Gross Margin (2015-2020)
Table Sanofi Pasteur Profile (Company Name, Plants Distribution, Sales Region)
Figure Sanofi Pasteur Sales and Growth Rate from 2015-2020
Figure Sanofi Pasteur Revenue ($) and Global Market Share from 2015-2020
Table Sanofi Pasteur Inactivated Vaccines Sales, Price, Revenue, Gross Margin (2015-2020)
Table Serum Institute Profile (Company Name, Plants Distribution, Sales Region)
Figure Serum Institute Sales and Growth Rate from 2015-2020
Figure Serum Institute Revenue ($) and Global Market Share from 2015-2020
Table Serum Institute Inactivated Vaccines Sales, Price, Revenue, Gross Margin (2015-2020)
Table CSL Limited Profile (Company Name, Plants Distribution, Sales Region)
Figure CSL Limited Sales and Growth Rate from 2015-2020
Figure CSL Limited Revenue ($) and Global Market Share from 2015-2020
Table CSL Limited Inactivated Vaccines Sales, Price, Revenue, Gross Margin (2015-2020)
Table MedImmune, LLC Profile (Company Name, Plants Distribution, Sales Region)
Figure MedImmune, LLC Sales and Growth Rate from 2015-2020
Figure MedImmune, LLC Revenue ($) and Global Market Share from 2015-2020
Table MedImmune, LLC Inactivated Vaccines Sales, Price, Revenue, Gross Margin (2015-2020)
Table Merck & Co Profile (Company Name, Plants Distribution, Sales Region)
Figure Merck & Co Sales and Growth Rate from 2015-2020
Figure Merck & Co Revenue ($) and Global Market Share from 2015-2020
Table Merck & Co Inactivated Vaccines Sales, Price, Revenue, Gross Margin (2015-2020)
Table Global Inactivated Vaccines Production Value ($) by Region from 2015-2020
Table Global Inactivated Vaccines Production Value Share by Region from 2015-2020
Table Global Inactivated Vaccines Production by Region from 2015-2020
Table Global Inactivated Vaccines Consumption Value ($) by Region from 2015-2020
Table Global Inactivated Vaccines Consumption by Region from 2015-2020
Table North America Inactivated Vaccines Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table North America Inactivated Vaccines Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table North America Inactivated Vaccines Import and Export from 2015-2020
Table North America Inactivated Vaccines Value ($) by Type (2015-2020)
Table North America Inactivated Vaccines Production by Type (2015-2020)
Table North America Inactivated Vaccines Consumption by Application (2015-2020)
Table North America Inactivated Vaccines Consumption by Country (2015-2020)
Table North America Inactivated Vaccines Consumption Value ($) by Country (2015-2020)
Figure North America Inactivated Vaccines Market PEST Analysis
Table Europe Inactivated Vaccines Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Europe Inactivated Vaccines Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Europe Inactivated Vaccines Import and Export from 2015-2020
Table Europe Inactivated Vaccines Value ($) by Type (2015-2020)
Table Europe Inactivated Vaccines Production by Type (2015-2020)
Table Europe Inactivated Vaccines Consumption by Application (2015-2020)
Table Europe Inactivated Vaccines Consumption by Country (2015-2020)
Table Europe Inactivated Vaccines Consumption Value ($) by Country (2015-2020)
Figure Europe Inactivated Vaccines Market PEST Analysis
Table Asia-Pacific Inactivated Vaccines Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Asia-Pacific Inactivated Vaccines Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Asia-Pacific Inactivated Vaccines Import and Export from 2015-2020
Table Asia-Pacific Inactivated Vaccines Value ($) by Type (2015-2020)
Table Asia-Pacific Inactivated Vaccines Production by Type (2015-2020)
Table Asia-Pacific Inactivated Vaccines Consumption by Application (2015-2020)
Table Asia-Pacific Inactivated Vaccines Consumption by Country (2015-2020)
Table Asia-Pacific Inactivated Vaccines Consumption Value ($) by Country (2015-2020)
Figure Asia-Pacific Inactivated Vaccines Market PEST Analysis
Table Latin America Inactivated Vaccines Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Latin America Inactivated Vaccines Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Latin America Inactivated Vaccines Import and Export from 2015-2020
Table Latin America Inactivated Vaccines Value ($) by Type (2015-2020)
Table Latin America Inactivated Vaccines Production by Type (2015-2020)
Table Latin America Inactivated Vaccines Consumption by Application (2015-2020)
Table Latin America Inactivated Vaccines Consumption by Country (2015-2020)
Table Latin America Inactivated Vaccines Consumption Value ($) by Country (2015-2020)
Figure Latin America Inactivated Vaccines Market PEST Analysis
Table Middle East & Africa Inactivated Vaccines Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Middle East & Africa Inactivated Vaccines Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Middle East & Africa Inactivated Vaccines Import and Export from 2015-2020
Table Middle East & Africa Inactivated Vaccines Value ($) by Type (2015-2020)
Table Middle East & Africa Inactivated Vaccines Production by Type (2015-2020)
Table Middle East & Africa Inactivated Vaccines Consumption by Application (2015-2020)
Table Middle East & Africa Inactivated Vaccines Consumption by Country (2015-2020)
Table Middle East & Africa Inactivated Vaccines Consumption Value ($) by Country (2015-2020)
Figure Middle East & Africa Inactivated Vaccines Market PEST Analysis
Table Global Inactivated Vaccines Value ($) and Growth Rate Forecast by Region (2020-2027)
Table Global Inactivated Vaccines Production and Growth Rate Forecast by Region (2020-2027)
Table Global Inactivated Vaccines Consumption and Growth Rate Forecast by Region (2020-2027)
Table Global Inactivated Vaccines Production and Growth Rate Forecast by Type (2020-2027)
Table Global Inactivated Vaccines Consumption and Growth Rate Forecast by Application (2020-2027)